A detailed history of Advantage Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Advantage Trust CO holds 1,054 shares of ABT stock, worth $129,873. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,054
Previous 1,306 19.3%
Holding current value
$129,873
Previous $136 Million 11.45%
% of portfolio
0.08%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$100.07 - $118.13 $25,217 - $29,768
-252 Reduced 19.3%
1,054 $120 Million
Q4 2023

Feb 07, 2024

BUY
$90.19 - $110.4 $117,788 - $144,182
1,306 New
1,306 $144 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $216B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Advantage Trust CO Portfolio

Follow Advantage Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advantage Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Advantage Trust CO with notifications on news.